Hepion Pharmaceuticals, Inc. (HEPA)

NASDAQ: HEPA · Real-Time Price · USD

0.3180

-0.0736 (-18.79%)

At close: May 12, 2025, 4:00 PM

0.1748

-0.1432 (-45.03%)

After-hours: May 12, 2025, 7:59 PM EDT

Hepion Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	7.5	9.62	10.35	10.01	8.15	Upgrade
Research & Development	11.85	35.64	33.27	20.4	12	Upgrade
Operating Expenses	19.35	45.26	43.62	30.4	20.15	Upgrade
Operating Income	-19.35	-45.26	-43.62	-30.4	-20.15	Upgrade
Interest Expense	-1.25	-0.01	-0.01	-0.01	-0.03	Upgrade
Other Non Operating Income (Expenses)	-3.17	-	-	-	-0.01	Upgrade
EBT Excluding Unusual Items	-23.76	-45.27	-43.63	-30.41	-20.18	Upgrade
Impairment of Goodwill	-	-	-1.87	-	-	Upgrade
Other Unusual Items	7.6	-0.88	0.41	-2.31	-0.14	Upgrade
Pretax Income	-16.16	-49.34	-45.08	-32.72	-20.32	Upgrade
Income Tax Expense	-2.97	-0.41	-2.88	-	0.03	Upgrade
Net Income	-13.19	-48.93	-42.2	-32.72	-20.35	Upgrade
Preferred Dividends & Other Adjustments	-	-	3.14	-	0.01	Upgrade
Net Income to Common	-13.19	-48.93	-45.34	-32.72	-20.36	Upgrade
Shares Outstanding (Basic)	0	0	0	0	-	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	-	Upgrade
Shares Change (YoY)	54.75%	4.18%	8.45%	-	-	Upgrade
EPS (Basic)	-107.35	-616.07	-594.75	-465.52	-	Upgrade
EPS (Diluted)	-107.35	-616.07	-594.75	-465.52	-	Upgrade
Free Cash Flow	-18.22	-40.9	-34.98	-31.35	-16.25	Upgrade
Free Cash Flow Per Share	-148.23	-515.05	-458.85	-446.07	-	Upgrade
EBITDA	-19.32	-45.19	-43.54	-30.32	-20.11	Upgrade
D&A For EBITDA	0.03	0.07	0.08	0.09	0.03	Upgrade
EBIT	-19.35	-45.26	-43.62	-30.4	-20.15	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q